$CBIS Elite Traders Group Reports on Three Big Potential

New Post Public Reply Private Reply Replies (0) Message Board
Depcom
$CBIS Elite Traders Group Reports on Three Big Potential Winners in the Medical Marijuana Industry


Since the Presidential election many marijuana stocks have been steadily climbing. Three companies are positioned and primed to continue this trend. These three companies are MediSwipe Inc. (OTCQB: MWIP), Cannabis Science Inc. (OTCQB: CBIS), and Medbox Inc. (PINKSHEETS: MDBX)
Like it or not, over the past decade 18 states have approved the use of medicinal marijuana. That is over a third of the country. The masses have spoken. Next election season will have even more states on the ballot. It is quickly becoming a preferred alternative to traditional treatments for patients with debilitating diseases like cancer, glaucoma, HIV/AIDS, hepatitis C, Crohn's disease, Parkinson's disease, ALS, or multiple sclerosis.

Colorado and Oregon have even passed laws for recreational use. A similar scenario would be the Netherlands in Europe. A large and organized group in Colorado has pushed for this law based on the opinion that it is considerably less dangerous than alcohol. Many cities across the U.S.A. have jumped on board in states where medicinal marijuana is legal. They have reduced the penalty from a felony to misdemeanor and some have made recreational use also.

The trend is clear. You can choose to sit on the sidelines or read about the following companies and see why we believe in their business model. The medical marijuana industry generated $1.7 billion in revenue nationwide last year, and is expected to grow to $8.9 billion by 2016, according to See Change Consulting Inc. of Olney, Md.

MediSwipe Inc. (OTCQB: MWIP)

MediSwipe, Inc. provides payment processing and financial services to medical businesses. The Company offers a spectrum of transaction processing solutions using traditional, Internet point-of-sale, e-commerce, and mobile (wireless) terminals in conjunction with industry alliance partners. This company has experience in providing payment and financial services for medical marijuana companies and is in a perfect spot to benefit from these new markets.

In addition, MediSwipe Inc. is in the process of spinning off 800Commerce Inc., which engages in the development and distribution of wireless applications through mobile marketing platforms that enable any business to integrate brands, promotions, video, and other digital content through the Internet and mobile devices. All shareholders of MediSwipe Inc. will receive a share dividend with the completion of the spinoff.

This company stands to be the best of the bunch. We believe in this company so much, we actually alerted Mediswipe Inc. to our early alert VIP members on Oct. 12 when it was at .0025/share. It is currently trading at .015, a gain of 500%. To find out more about our VIP early alert service, please visit: http://www.firstpennypicks.com/vip-membership/

Medbox, Inc. (PINKSHEETS: MDBX)

Medbox, Inc. has an amazing 52 week range of .03 to 215.00/share, currently trading around 61.00/share. Medbox offers a dispensary solution for medical marijuana patients much like Redbox offers movie rentals. Medbox recently brought on a Director of Mergers and Acquisitions, so there is no doubt they have something up their sleeve at this point.

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide (Get Full Analysis for Free) http://www.firstpennypicks.com/get-your-free-...ch-report/

Cannabis Science Inc. (OTCQB: CBIS)

Cannabis Science Inc. is more involved with scientific aspect in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. This industry is just beginning to scratch the surface of the endless possibilities that could come from R & D. Cannabis Science Inc. is on the cutting edge of this research.

We believe that this company will continue to show the gains they have shown since the election. They are up an incredible 50% and moving in the right direction. (Get Full Analysis for Free) http://www.firstpennypicks.com/get-your-free-...ch-report/

http://www.Firstpennypicks.com was developed as a beacon of hope in the small and Micro-Cap stock newsletter industry. By hand picking our profiles we are able to offer a more interactive and trader friendly service in an industry full of biased advertisers.

For future updates and our weekly feature alerts subscribe free here: http://www.Firstpennypicks.com

VIP GROUP

Increase Your Day Trading Profits by joining our VIP Pre-promotion/Early Alert Membership For only $29.95/month or $295/Year: http://www.firstpennypicks.com/vip-membership/

READ OUR FULL DISCLAIMER HERE: http://www.firstpennypicks.com/disclaimer/

Contact:

Elite Traders Group LLC

Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading